Szeged, Hungary

Eva Udvardy

This inventor holds 1 USPTO granted patent. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1982.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eva Udvardy: Innovator in Chemical Compounds

Introduction

Eva Udvardy is a notable inventor based in Szeged, Hungary. She has made significant contributions to the field of chemistry, particularly in the development of new chemical compounds. Her work has implications for various applications in pharmaceuticals and materials science.

Latest Patents

Eva Udvardy holds a patent for "1,2,4-Oxadiazolin-5-one derivatives, process for their preparation." This invention concerns new compounds of the formula (I), wherein R¹ can be hydrogen, phenyl, or phenyl substituted with at least one alkyl having 1 to 4 carbon atoms, halogen, alkoxy having 1 to 4 carbon atoms, or nitro. This innovative work showcases her expertise in creating novel chemical structures.

Career Highlights

Throughout her career, Eva has demonstrated a commitment to advancing chemical research. She is currently associated with Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt., a prominent pharmaceutical company in Hungary. Her role at the company allows her to apply her inventive skills in a practical setting, contributing to the development of new medicinal products.

Collaborations

Eva has collaborated with several talented individuals in her field, including Peter Literati Nagy and Maria Hetyey Nee Papp. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Eva Udvardy is a distinguished inventor whose work in chemical compounds has the potential to impact various industries. Her dedication to research and collaboration continues to drive advancements in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…